Gilead Sciences (NASDAQ: GILD) last traded at $146.12, up 1.87% on the session. The quote above updates while this page is open; the figures below are drawn from Gilead Sciences’s own filings and are restated only when a new one is published.
Gilead Sciences trades on NASDAQ under the ticker GILD. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $181.18 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Gilead Sciences, derived from the latest quote and its most recent SEC filing.
| Market cap | $181.18B |
|---|---|
| Price / sales | 5.95 |
| Price / book | 15.32 |
| Beta | 0.33 |
Trailing-twelve-month figures tagged in Gilead Sciences's XBRL filings with the SEC.
| Revenue (TTM) | $30.46B |
|---|---|
| Net income (TTM) | -$3.24B |
| EPS (TTM) | -$2.66 |
| Operating margin | -8.20% |
| Return on equity | -27.39% |
Range and volume for GILD over the past 52 weeks.
| 52-week high | $157.29 |
|---|---|
| 52-week low | $108.46 |
| Volume | 5.38M |
| Average volume | 7.69M |
| Previous close | $143.44 |
Dividend history for Gilead Sciences over the trailing twelve months.
| Dividend yield | 2.20% |
|---|---|
| Dividend per share (TTM) | $3.22 |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.